Mild Cognitive Impairment (MCI) is associated with early stages of neurodegenerative diseases like Alzheimer’s and other dementias. Many people living with dementia cite symptoms of MCI as an early sign. Yet, there’s lots of confusion with what might be “normal” memory loss that comes with aging or a sign to see a doctor. UCSF’s Emily Paolillo, PhD, joins Being Patient Live Talks to explain MCI and what goes into diagnosis. As an Assistant Professor at the UCSF Memory and Aging Center, her clinical work includes providing neuropsychological evaluations to aid in diagnosis and treatment of patients with possible neurodegenerative diseases. In addition, her research focuses on evaluating digital health tools for early detection and monitoring of neurobehavioral changes in Alzheimer’s disease, as well as understanding how lifestyle behaviors can grant risk and resilience to dementia. RSVP to this live talk to learn more about MCI and what to keep in mind about diagnosis. If you loved watching this Live Talk, visit our website to find more of our Alzheimer’s coverage and subscribe to our newsletter: https://www.beingpatient.com/ Follow Being Patient: Twitter: / being_patient_ Instagram: / beingpatientvoices Facebook: / beingpatientalzheimers LinkedIn: / being-patient Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category...#Alzheimers #Dementia #MCI #BrainHealth

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related